NMR uncovers direct interaction between human NEDD4-1 and p34SEI−1
Authors:
- 1 August 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 490 (3) , 984-990
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
- National Research Foundation of Korea
This publication has 31 references indexed in Scilit:
- Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cellsLung Cancer, 2011
- Advances in Development of Phosphatidylinositol 3-Kinase InhibitorsCurrent Medicinal Chemistry, 2009
- Metastasis and AKT activationCell Cycle, 2008
- Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promisesCurrent Opinion in Pharmacology, 2008
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerationsDrug Resistance Updates, 2008
- Akt/PKB Signaling in Cancer: A Function in Cell Motility and InvasionCell Cycle, 2006
- Phosphoinositide 3-Kinase Signalling Pathways in Tumor Progression, Invasion and AngiogenesisTumori Journal, 2004
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-TrisphosphateJournal of Biological Chemistry, 1998
- Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domainProceedings of the National Academy of Sciences, 1997